Baillie Gifford & Co

Baillie Gifford & Co Portfolio holdings

AUM $134B
1-Year Return 51.86%
 

Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.

This Quarter Return
-16.55%
1 Year Return
+51.86%
3 Year Return
+235.75%
5 Year Return
+330.72%
10 Year Return
+1,748.3%
AUM
$143B
AUM Growth
-$39.6B
Cap. Flow
-$3.99B
Cap. Flow %
-2.8%
Top 10 Hldgs %
39.86%
Holding
510
New
11
Increased
135
Reduced
148
Closed
12

Top Sells

1
TSLA icon
Tesla
TSLA
$1.06B
2
PBR icon
Petrobras
PBR
$460M
3
BABA icon
Alibaba
BABA
$450M
4
Z icon
Zillow
Z
$381M
5
NVDA icon
NVIDIA
NVDA
$379M

Sector Composition

1 Consumer Discretionary 28.1%
2 Healthcare 23.85%
3 Technology 19.62%
4 Communication Services 11.36%
5 Financials 5.81%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ADEA icon
326
Adeia
ADEA
$1.69B
$27K ﹤0.01%
5,855
AZN icon
327
AstraZeneca
AZN
$253B
$27K ﹤0.01%
400
BCRX icon
328
BioCryst Pharmaceuticals
BCRX
$1.74B
$27K ﹤0.01%
1,687
+187
+12% +$2.99K
EXEL icon
329
Exelixis
EXEL
$10.2B
$27K ﹤0.01%
1,200
CNS icon
330
Cohen & Steers
CNS
$3.7B
$26K ﹤0.01%
301
CRWD icon
331
CrowdStrike
CRWD
$105B
$26K ﹤0.01%
114
EGHT icon
332
8x8 Inc
EGHT
$282M
$26K ﹤0.01%
2,045
EXPO icon
333
Exponent
EXPO
$3.61B
$26K ﹤0.01%
242
FDS icon
334
Factset
FDS
$14B
$26K ﹤0.01%
61
JAZZ icon
335
Jazz Pharmaceuticals
JAZZ
$7.86B
$26K ﹤0.01%
165
KN icon
336
Knowles
KN
$1.85B
$26K ﹤0.01%
1,200
PFE icon
337
Pfizer
PFE
$141B
$26K ﹤0.01%
500
SEIC icon
338
SEI Investments
SEIC
$10.8B
$26K ﹤0.01%
438
VNE
339
DELISTED
Veoneer, Inc.
VNE
$26K ﹤0.01%
700
GGG icon
340
Graco
GGG
$14.2B
$25K ﹤0.01%
363
BRSL
341
Brightstar Lottery PLC
BRSL
$3.18B
$25K ﹤0.01%
1,024
RGNX icon
342
Regenxbio
RGNX
$490M
$25K ﹤0.01%
+752
New +$25K
VC icon
343
Visteon
VC
$3.41B
$25K ﹤0.01%
230
INFN
344
DELISTED
Infinera Corporation Common Stock
INFN
$25K ﹤0.01%
2,941
SPWR
345
DELISTED
SunPower Corporation Common Stock
SPWR
$25K ﹤0.01%
1,171
APPF icon
346
AppFolio
APPF
$10.2B
$24K ﹤0.01%
212
GLW icon
347
Corning
GLW
$61B
$24K ﹤0.01%
653
HUM icon
348
Humana
HUM
$37B
$24K ﹤0.01%
56
AYX
349
DELISTED
Alteryx, Inc.
AYX
$24K ﹤0.01%
336
DCI icon
350
Donaldson
DCI
$9.44B
$23K ﹤0.01%
436